Anatomic Pathology Testing market Will Generate New Growth Opportunities By 2025

Posted by Aniket Ankushrao on July 15th, 2019

Global Anatomic Pathology Testing Market: Snapshot

Anatomic pathology, or anatomical pathology, entails biochemical, microscopic, and molecular examination of tissues and organs to uncover abnormalities in them. This helps to diagnose diseases and manage treatment. Although most commonly used to detect and manage different kinds of cancer and tumors, it is also useful in evaluating other health conditions such as kidney and liver diseases, infections, and autoimmune diseases.

The two different types of anatomic pathology testing products are instruments and consumables. Instruments include slides, microscope, centrifuges, and cassette printers, while consumables include reagents, kits, and antibodies. The two different services in the anatomic pathology testing market are cytopathology and histopathology. Anatomic pathology testing finds application in hospitals, clinical diagnostic laboratories, and physician office laboratories.

From a geographical standpoint, North America is a key region in the anatomic pathology testing market because of the growing prevalence of cancer and other chronic diseases. Europe is another key region and is propelled by the large pool of elderly population that is highly susceptible to chronic diseases and surging popularity of personalized medicine and digital laboratory.

Asia Pacific is a lucrative market owing to the rising investment by governments and academic institutions in diagnostic research and increasing awareness about anatomic pathology tests. In addition, globalization, improving economies, and changing lifestyle is also stoking growth in the market in the region.

Some of the prominent participants in the global anatomic pathology testing market are Neogenomics Laboratories, Inc., Abbott Diagnostic International Ltd., Danaher, Agilent Technologies, Bio SB, Roche Diagnostics, and Quest Diagnostics Incorporated.

Anatomic pathology is a branch of science or branch of medicine that primarily involves microscopic, biochemical, and molecular examination of organs and tissues to find out the effectiveness of diseases. The key objective of anatomic pathology is to identify abnormalities in order to manage diagnosis and treatment. Anatomic pathology helps to detect various types of tumor and cancer. It is also sometimes useful to evaluate the liver and kidney diseases effectively. Gross examination, histopathology, immunohistochemistry, cytopathology, and flow immunophenotyping are some of the procedures carried out during anatomic pathology test. Anatomic pathology testing is a superspeciality test. To perform this type of test, a person should have a qualified certification from a recognized body such as the American Board of Pathology or the American Osteopathic Board of Pathology. Anatomic pathologist is also involved in post mortem examination. Like clinical pathology reports, anatomic pathology reports also contain essential elements such as name, number, sample type, and source. Many anatomic pathology departments operate according to the specific need of a patient.

The anatomic pathology testing market has been segmented based on product, services, and application. In terms of product, the market has been categorized into instruments and consumables. Instruments such as microscope, centrifuges, slides, and cassette printers are used to conduct anatomic pathology tests. Consumables include kits, reagents, and antibodies. Based on services, the anatomic pathology testing market has been segmented into cytopathology and histopathology. In terms of application, the market has been categorized into breast cancer diagnosis, lung cancer diagnosis, and cervical cancer diagnosis. Based on end-user, the global anatomic pathology testing market has been segmented into clinical diagnostic laboratories, hospitals, and physician office laboratories. Increasing prevalence of chronic diseases, maximum use of biomarkers, direct to customer facility, and government awareness about early cancer detection and diagnosis are likely to boost the growth of the anatomic pathology testing market. High cost of digital imaging, poor resolution, set up costs, lack of depth perception are some of the factors restraining the market.

Geographically, the anatomic pathology testing market is dominated by North America due to rising incidence of cancer and epathology solutions. Rising prevalence of chronic diseases, rapid increase in geriatric population, and high acceptance of personalized medicine and digital laboratory propel the market in Europe. Growing academic and government investment in diagnostic research and rising awareness about the use of anatomic pathology test among physicians are projected to boost the growth of the market in Asia Pacific. Increasing globalization, sound economy, and changing lifestyle habits of the population in the region has led to the growth of the anatomy pathology testing market in Latin America. High life expectancy, increasing burden of diseases, increasing chronic and non-communicable diseases such as diabetes, cancer, and obesity fuel the growth of the anatomic pathology testing market. Improving living standards, and increasing demand for quality medicines in Middle East & Africa boost the growth of the anatomy pathology testing market in the region.

Request Brochure of the Report:

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=26852

Major players in the anatomic pathology testing market are Abbott Diagnostic International Ltd., Agilent Technologies, Danaher, Roche Diagnostics, Bio SB, Neogenomics Laboratories, Inc., and Quest Diagnostics Incorporated.https://www.transparencymarketresearch.com/